M9 Biopharmaceutics Classification System-Based Biowaivers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 11, 2021
May 2, 2023
bf9d33a6-a7bf-4b4e-bf7a-2a88d1e6d1cf
Related Documents
M10 Bioanalytical Method Validation and Study Sample Analysis
Guidance DocumentNovember 4, 2022Center for Drug Evaluation and Research
Q9(R1) Quality Risk Management
Guidance DocumentMay 3, 2023Center for Drug Evaluation and Research
Q3C(R8) Impurities: Guidance for Residual Solvents Guidance for Industry: Guidance for Industry
Guidance DocumentDecember 10, 2021Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox